Atlas Trials

BRAF V600 Mutation Positive Melanoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch BRAF V600 Mutation Positive Melanoma

RecordFirmDate
A Multi-center Retrospective Study With Secondary Use of Data of Tafinlar (Dabrafenib) Plus Mekinist (Trametinib) in Chinese Patients With BRAF V600 Mutation Positive Melanoma (NCT06337617)Novartis Pharmaceuticals2022-05-10

Track BRAF V600 Mutation Positive Melanoma automatically

Every clearance here is in the API, with alerts when new ones post.